Skip to content

EPS (Diluted) at other companies

OSI Systems logo
OSI SystemsOSIS
$2.33-2.9%
iRadimed logo
iRadimedIRMD
$0.45+21.6%
HTF
Heartflow, Inc. Common StockHTFL
-$0.32+93.9%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$1.80+76.5%
Butterfly Network logo
Butterfly NetworkBFLY
-$0.05+16.7%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
-$0.25+79.3%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-13.0%
P/E15.2×+0.3×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's EPS (diluted)?
GE HealthCare Technologies (GEHC) reported EPS (diluted) of $0.85 in Q1 2026.
How has GE HealthCare Technologies's EPS (diluted) changed year-over-year?
GE HealthCare Technologies's EPS (diluted) decreased by 30.9% year-over-year, from $1.23 to $0.85.
What is the long-term trend for GE HealthCare Technologies's EPS (diluted)?
Over 4 years (2021 to 2025), GE HealthCare Technologies's EPS (diluted) has grown at a -2.0% compound annual growth rate (CAGR), from $4.95 to $4.56.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.